Cargando…

Accurate determination of epitope for antibodies with unknown 3D structures

MAbTope is a docking-based method for the determination of epitopes. It has been used to successfully determine the epitopes of antibodies with known 3D structures. However, during the antibody discovery process, this structural information is rarely available. Although we already have evidence that...

Descripción completa

Detalles Bibliográficos
Autores principales: Tahir, Shifa, Bourquard, Thomas, Musnier, Astrid, Jullian, Yann, Corde, Yannick, Omahdi, Zakaria, Mathias, Laetitia, Reiter, Eric, Crépieux, Pascale, Bruneau, Gilles, Poupon, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405158/
https://www.ncbi.nlm.nih.gov/pubmed/34432559
http://dx.doi.org/10.1080/19420862.2021.1961349
_version_ 1783746275436396544
author Tahir, Shifa
Bourquard, Thomas
Musnier, Astrid
Jullian, Yann
Corde, Yannick
Omahdi, Zakaria
Mathias, Laetitia
Reiter, Eric
Crépieux, Pascale
Bruneau, Gilles
Poupon, Anne
author_facet Tahir, Shifa
Bourquard, Thomas
Musnier, Astrid
Jullian, Yann
Corde, Yannick
Omahdi, Zakaria
Mathias, Laetitia
Reiter, Eric
Crépieux, Pascale
Bruneau, Gilles
Poupon, Anne
author_sort Tahir, Shifa
collection PubMed
description MAbTope is a docking-based method for the determination of epitopes. It has been used to successfully determine the epitopes of antibodies with known 3D structures. However, during the antibody discovery process, this structural information is rarely available. Although we already have evidence that homology models of antibodies could be used instead of their 3D structure, the choice of the template, the methodology for homology modeling and the resulting performance still have to be clarified. Here, we show that MAbTope has the same performance when working with homology models of the antibodies as compared to crystallographic structures. Moreover, we show that even low-quality models can be used. We applied MAbTope to determine the epitope of dupilumab, an anti- interleukin 4 receptor alpha subunit therapeutic antibody of unknown 3D structure, that we validated experimentally. Finally, we show how the MAbTope-determined epitopes for a series of antibodies targeting the same protein can be used to predict competitions, and demonstrate the accuracy with an experimentally validated example. 3D: three-dimensionalRMSD: root mean square deviationCDR: complementary-determining regionCPU: central processing unitsVH: heavy chain variable regionVL: light chain variable regionscFv: single-chain variable fragmentsVHH: single-chain antibody variable regionIL4Rα: Interleukin 4 receptor alpha chainSPR: surface plasmon resonancePDB: protein data bankHEK293: Human embryonic kidney 293 cellsEDTA: Ethylenediaminetetraacetic acidFBS: Fetal bovine serumANOVA: Analysis of varianceEGFR: Epidermal growth factor receptorPE: PhycoerythrinAPC: AllophycocyaninFSC: forward scatterSSC: side scatterWT: wild type Keywords: MAbTope, Epitope Mapping, Molecular docking, Antibody modeling, Antibody-antigen docking
format Online
Article
Text
id pubmed-8405158
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-84051582021-08-31 Accurate determination of epitope for antibodies with unknown 3D structures Tahir, Shifa Bourquard, Thomas Musnier, Astrid Jullian, Yann Corde, Yannick Omahdi, Zakaria Mathias, Laetitia Reiter, Eric Crépieux, Pascale Bruneau, Gilles Poupon, Anne MAbs Report MAbTope is a docking-based method for the determination of epitopes. It has been used to successfully determine the epitopes of antibodies with known 3D structures. However, during the antibody discovery process, this structural information is rarely available. Although we already have evidence that homology models of antibodies could be used instead of their 3D structure, the choice of the template, the methodology for homology modeling and the resulting performance still have to be clarified. Here, we show that MAbTope has the same performance when working with homology models of the antibodies as compared to crystallographic structures. Moreover, we show that even low-quality models can be used. We applied MAbTope to determine the epitope of dupilumab, an anti- interleukin 4 receptor alpha subunit therapeutic antibody of unknown 3D structure, that we validated experimentally. Finally, we show how the MAbTope-determined epitopes for a series of antibodies targeting the same protein can be used to predict competitions, and demonstrate the accuracy with an experimentally validated example. 3D: three-dimensionalRMSD: root mean square deviationCDR: complementary-determining regionCPU: central processing unitsVH: heavy chain variable regionVL: light chain variable regionscFv: single-chain variable fragmentsVHH: single-chain antibody variable regionIL4Rα: Interleukin 4 receptor alpha chainSPR: surface plasmon resonancePDB: protein data bankHEK293: Human embryonic kidney 293 cellsEDTA: Ethylenediaminetetraacetic acidFBS: Fetal bovine serumANOVA: Analysis of varianceEGFR: Epidermal growth factor receptorPE: PhycoerythrinAPC: AllophycocyaninFSC: forward scatterSSC: side scatterWT: wild type Keywords: MAbTope, Epitope Mapping, Molecular docking, Antibody modeling, Antibody-antigen docking Taylor & Francis 2021-08-25 /pmc/articles/PMC8405158/ /pubmed/34432559 http://dx.doi.org/10.1080/19420862.2021.1961349 Text en © 2021 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Report
Tahir, Shifa
Bourquard, Thomas
Musnier, Astrid
Jullian, Yann
Corde, Yannick
Omahdi, Zakaria
Mathias, Laetitia
Reiter, Eric
Crépieux, Pascale
Bruneau, Gilles
Poupon, Anne
Accurate determination of epitope for antibodies with unknown 3D structures
title Accurate determination of epitope for antibodies with unknown 3D structures
title_full Accurate determination of epitope for antibodies with unknown 3D structures
title_fullStr Accurate determination of epitope for antibodies with unknown 3D structures
title_full_unstemmed Accurate determination of epitope for antibodies with unknown 3D structures
title_short Accurate determination of epitope for antibodies with unknown 3D structures
title_sort accurate determination of epitope for antibodies with unknown 3d structures
topic Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405158/
https://www.ncbi.nlm.nih.gov/pubmed/34432559
http://dx.doi.org/10.1080/19420862.2021.1961349
work_keys_str_mv AT tahirshifa accuratedeterminationofepitopeforantibodieswithunknown3dstructures
AT bourquardthomas accuratedeterminationofepitopeforantibodieswithunknown3dstructures
AT musnierastrid accuratedeterminationofepitopeforantibodieswithunknown3dstructures
AT jullianyann accuratedeterminationofepitopeforantibodieswithunknown3dstructures
AT cordeyannick accuratedeterminationofepitopeforantibodieswithunknown3dstructures
AT omahdizakaria accuratedeterminationofepitopeforantibodieswithunknown3dstructures
AT mathiaslaetitia accuratedeterminationofepitopeforantibodieswithunknown3dstructures
AT reitereric accuratedeterminationofepitopeforantibodieswithunknown3dstructures
AT crepieuxpascale accuratedeterminationofepitopeforantibodieswithunknown3dstructures
AT bruneaugilles accuratedeterminationofepitopeforantibodieswithunknown3dstructures
AT pouponanne accuratedeterminationofepitopeforantibodieswithunknown3dstructures